CE stock · XTNT stock

CE vs XTNT · rev $10.28B vs rev $133.9M

Celanese Corporation (CE) versus Xtant Medical Holdings Inc (XTNT) — a side-by-side from cached financials, not a winner call.

Celanese Corporation (CE) is a chemicals company listed on US.

Xtant Medical Holdings Inc (XTNT) is a medical devices company listed on US.

Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.

Latest reported XTNT revenue for 2025-12-31 was $133.9M. Net income was $5.0M. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. XTNT currently screens at market cap $91.0M.

CE currently screens at market cap $5.92B. XTNT currently screens at market cap $91.0M.

Not investment advice. Open the CE and XTNT stock pages for the full models.

Not investment advice.

Popular Stock Comparisons